Kertscher H P, Ostermann G, Findeisen M, Limmer S, Gawrisch K
Sektion Biowissenschaften, Universität Leipzig.
Pharmazie. 1991 Aug;46(8):575-9.
A series of analogues of platelet-activating factor (PAF) with heteroarene head groups have been synthesized, and tested for biological activities on blood platelets in vitro. In comparison with PAF most of the structural modifications exerted weak proaggregatory effects. The 4-(dimethylamino)pyridinium compound did not activate platelets but inhibited selectively PAF-induced platelet responses. These results point to a crucial role of the distance between the phosphoryl group and polar head for expression of PAF-antagonistic properties. Structural features of PAF-antagonist have been investigated by two-dimensional proton NMR spectroscopy, and proposed a model with three-dimensional structure.
一系列具有杂芳烃头部基团的血小板活化因子(PAF)类似物已被合成,并在体外对血小板的生物活性进行了测试。与PAF相比,大多数结构修饰产生的促聚集作用较弱。4-(二甲基氨基)吡啶鎓化合物不激活血小板,但能选择性抑制PAF诱导的血小板反应。这些结果表明磷酰基与极性头部之间的距离对于PAF拮抗特性的表达起着关键作用。通过二维质子核磁共振光谱研究了PAF拮抗剂的结构特征,并提出了一个具有三维结构的模型。